The setting at Community level of such provisional maximum residue levels does not prevent the Member States from establishing provisional maximum residue levels for spiroxamine in accordance with Article 4(1)(f) of Directive 91/414/EEC, and in accordance with Annex VI to Directive 91/414/EEC, in particular part B, section 2.4.2.3 of this Annex; four years is considered a sufficient period of time during which to establish most further uses of spiroxamine.
Jääkide ajutiste piirnormide kehtestamine ühenduse tasandil ei takista liikmesriikidel kehtestada spiroksamiini jääkide piirnorme vastavalt direktiivi 91/414/EMÜ artikli 4 lõike 1 punktile f ja vastavalt direktiivi 91/414/EMÜ VI lisale, eriti selle B osa punktile 2.4.2.3; nelja aastat peetakse spiroksamiini peamiste edasiste kasutusviiside kindlakstegemiseks piisavaks.